Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
312 Identification of novel NSC lung cancer Dark Antigens™ with expression in multiple tumor types, as promising targets for immunotherapies
Compose a Response to This Article
Other responses
No responses have been published for this article.